Status:
ACTIVE_NOT_RECRUITING
Post-Market Registry in Europe and US for the Use of VascuCelTM
Lead Sponsor:
LeMaitre Vascular
Collaborating Sponsors:
Avania
Conditions:
Great Vessel Reconstruction
Peripheral Vessel Reconstruction
Eligibility:
All Genders
Brief Summary
This is a post-market, multi-centre, open-label registry designed to collect prospective safety and performance data on the use of VascuCel in patients who require great vessel reconstruction, periphe...
Detailed Description
Post-market, prospective, multi-centre, open-label, registry designed to collect prospective safety and performance data on the use of VascuCel in patients with vascular disorders and in accordance wi...
Eligibility Criteria
Inclusion
- patient has signed the informed consent
- patient is a candidate for treatment with VascuCel per approved device indications.
Exclusion
- no study specific exclusion criteria; patients treated per standard clinical practice
Key Trial Info
Start Date :
June 9 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 1 2026
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04906824
Start Date
June 9 2023
End Date
September 1 2026
Last Update
March 10 2025
Active Locations (5)
Enter a location and click search to find clinical trials sorted by distance.
1
Kootenai Health
Coeur d'Alene, Idaho, United States, 83814
2
Eddy Luh
Las Vegas, Nevada, United States, 27599
3
Westchester Medical Center
Valhalla, New York, United States, 10595
4
University North Carolina
Chapel Hill, North Carolina, United States, 27599